Cargando…
Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States
In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projected the fracture burden in US women by modeling the expected...
Autores principales: | Lewiecki, E Michael, Ortendahl, Jesse D, Vanderpuye‐Orgle, Jacqueline, Grauer, Andreas, Arellano, Jorge, Lemay, Jeffrey, Harmon, Amanda L, Broder, Michael S, Singer, Andrea J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808223/ https://www.ncbi.nlm.nih.gov/pubmed/31667450 http://dx.doi.org/10.1002/jbm4.10192 |
Ejemplares similares
-
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
por: Juday, Timothy, et al.
Publicado: (2013) -
Management of osteoporosis
por: Lewiecki, E Michael
Publicado: (2004) -
Operationalizing Treat-to-Target for Osteoporosis
por: Lewiecki, E. Michael
Publicado: (2021) -
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009) -
Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011)